INDIUM IN 111 CHLORIDE solution United States - English - NLM (National Library of Medicine)

indium in 111 chloride solution

curium us llc - indium chloride in-111 (unii: 58td96h03i) (indium cation in-111 - unii:wjz06c0h8l) - indium cation in-111 10 mci in 1 ml - indium in 111 chloride sterile solution is indicated for radiolabeling prostascint preparations used for in vivo diagnostic imaging procedures. it is also indicated for radiolabeling zevalin preparations used for radioimmunotherapy procedures. please refer to the package insert for prostascint or zevalin for information on the final drug product. please refer to the package insert for prostascint or zevalin for this information on the final drug product.

INDIUM IN 111 OXYQUINOLINE- indium in-111 oxyquinoline solution United States - English - NLM (National Library of Medicine)

indium in 111 oxyquinoline- indium in-111 oxyquinoline solution

medi-physics inc. dba ge healthcare. - indium in-111 oxyquinoline (unii: lgx9ol562t) (indium cation in-111 - unii:wjz06c0h8l) - indium cation in-111 1 ug in 1 ml - indium in 111 oxyquinoline solution is indicated for radiolabeling autologous leukocytes. indium in 111 oxyquinoline labeled leukocytes may be used as an adjunct in the detection of inflammatory processes to which leukocytes migrate, such as those associated with abscesses or other infection, following reinjection and detection by appropriate imaging procedures. the degree of accuracy may vary with labeling techniques and with the size, location and nature of the inflammatory process. indium in 111 oxyquinoline labeled leukocyte imaging is not the preferred technique for the initial evaluation of patients with a high clinical probability of an abscess in a known location. ultrasound or computed tomography may provide a better anatomical delineation of the infectious process and information may be obtained more quickly than with labeled leukocytes. if localization by these techniques is successful, labeled leukocytes should not be used as a confirmatory procedure. if localization or diagnosis by these methods fails or is ambiguous, indium in 111 oxyquinoline labeled leukocyte imaging may be appropriate. none known.

INDIUM DTPA IN 111- indium in-111 pentetate disodium solution United States - English - NLM (National Library of Medicine)

indium dtpa in 111- indium in-111 pentetate disodium solution

medi-physics, inc. dba ge healthcare - indium in-111 pentetate disodium (unii: 7uit3zgc8e) (indium cation in-111 - unii:wjz06c0h8l) - indium cation in-111 1 mci in 1 ml - pentetate indium disodium in 111 is recommended for use in radionuclide cisternography. none known.

Indium (In111) Chloride 370MBq/ml radiopharmaceutical precursor Ireland - English - HPRA (Health Products Regulatory Authority)

indium (in111) chloride 370mbq/ml radiopharmaceutical precursor

curium netherlands b.v. - indium (111 in) - radiopharmaceutical precursor, solution - 370 mbq/ml - indium (111in) pentetic acid

Indium (111In) DTPA 37MBq/ml Solution for Injection Ireland - English - HPRA (Health Products Regulatory Authority)

indium (111in) dtpa 37mbq/ml solution for injection

curium netherlands b.v. - indium (111 in); pentetic acid - solution for injection - 37 mbq/ml - indium (111in) pentetic acid

INDIUM 111 OXYQUINOLONE solution United States - English - NLM (National Library of Medicine)

indium 111 oxyquinolone solution

anazaohealth corporation - indium in-111 oxyquinoline (unii: lgx9ol562t) (indium in-111 oxyquinoline - unii:lgx9ol562t) - indium in-111 oxyquinoline 2 mci in 1 ml - this preparation is supplied as a sterile, non-pyrogenic, isotonic aqueous solution with a ph range of 6.5 to 7.5 and is not for direct injection. each milliliter contains 2 mci at calibration time, 50μg oxyquinoline, 100μg polysorbate 80, and 6 mg of hepes (n-2-hydroxyethyl-piperazine-n’-2-ethane sulfonic acid) buffer in 0.75% sodium chloride solution. it is intended for single use only and contains no bacteriostatic agent.

INDIUM IN 111 OXYQUINOLINE- indium in-111 oxyquinoline liquid United States - English - NLM (National Library of Medicine)

indium in 111 oxyquinoline- indium in-111 oxyquinoline liquid

bwxt medical ltd. - indium in-111 oxyquinoline (unii: lgx9ol562t) (indium cation in-111 - unii:wjz06c0h8l) - indium in 111 oxyquinoline is indicated for radiolabeling autologous leukocytes. indium in 111 oxyquinoline labeled leukocytes may be used as an adjunct in the detection of inflammatory processes to which leukocytes migrate, such as those associated with abscesses or other infection, following reinjection and detection by appropriate imaging procedures. the degree of accuracy may vary with labeling techniques and with the size, location and nature of the inflammatory process. indium in 111 oxyquinoline labeled leukocyte imaging is not the preferred technique for the initial evaluation of patients with a high clinical probability of an abscess in a known location. ultrasound or computed tomography may provide a better anatomical delineation of the infectious process and information may be obtained more quickly than with labeled leukocytes. if localization by these techniques is successful, labeled leukocytes should not be used as a confirmatory procedure. if localization or diagnosis by these methods fails or

Indium (In-111) Chloride Curium 370 MBq/ml radiopharmac. precursor i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

indium (in-111) chloride curium 370 mbq/ml radiopharmac. precursor i.v. vial

curium belgium s.p.r.l.-b.v.b.a. - indium (111 in) chloride 370 mbq/ml - radiopharmaceutical precursor - 370 mbq/ml - indium (in-111) chloride 370 mbq/ml - indium (111in) compounds

Indium (In111) DTPA Curium 37 MBq/ml inj. sol. i.thec. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

indium (in111) dtpa curium 37 mbq/ml inj. sol. i.thec. vial

curium belgium s.p.r.l.-b.v.b.a. - indium (111 in) pentetate 37 mbq/ml - solution for injection - 37 mbq/ml - indium (in-111)-calcium-dtpa complex 37 mbq/ml - indium (111in) pentetic acid

Indium(111In) pentetate 37MBq/mL injection Australia - English - Department of Health (Therapeutic Goods Administration)

indium(111in) pentetate 37mbq/ml injection

australian nuclear science and technology organisation t/a ansto - indium (111in) pentetate, quantity: 37 mbq/ml - injection, solution - excipient ingredients: water for injections; pentetic acid; sodium bicarbonate - indications as at 11 jan 05 : radionuclide cisternography.